acid-13 C 5 ; L-isoleucine-13 C 6 , 15 N; L-leucine-13 C 6 , L-tryptophan-13 C 11 , 15 N 2 ; L-glutamine-13 C 5 ; creatinine-(methyl-d 3 ), cytidine-5,6-d 2 ; and benzoic acid-phenyl-13 C 6 . Six of these standards were determined to be suitable for analysis of RPC+ data quality, while seven were found suitable for analysis RPC-data (see Table 1 (hippuric acid) was prepared for use in both chromatographic assay types as a two-point IS.
Reversed-phase chromatography (RPC) method development.
Step Time(min) Flow (mL/min) %A %B Figure SI-1. Representative system pressure trace produced by the RPC method.
Hydrophillic interaction liquid chromatography (HILIC) method development.
Step Time(min) Flow (mL/min) %A %B Optimization of UPLC-MS system configuration.
As a general guide, ion source parameters were selected that favored system robustness (e.g. signal stability over time), but adjusted to minimize the negative impact on other important characteristics like signal intensity (which must be promoted to allow for injection of less sample). Instrument specific optimized ion source and ion guide settings were as follows for all assays: capillary = 1.5/1.0kV (+/-), cone = 20V, source offset = 80V, and StepWave 2 offset = 10V. The cone gas flow was adjusted by first reasoning that greater gas flow exiting the cone was better for keeping the source clean against electrospray material deposit, and then increasing the cone gas until a negative effect was observed in the signal intensity of method reference standards. A value slightly less than this maximum was then selected (150 L/hr), and in this case was a common setting for this instrument type.
The remaining parameters were adjusted to promote sensitivity. MS instrument tuning was performed by infusion of cytidine (m/z = 244.0933) for positive ion mode and citric acid (m/z = 191.0192) for negative ion mode, irrespective of chromatographic assay type. Acceleration 1, acceleration 2, and aperture 2 voltages were adjusted to maximize sensitivity, followed by adjustment of steering, pusher offset, and reflectron grid to achieve symmetrical peak shape and maximum Sample sorting, formatting, and aliquoting. Urine samples from each study were received on dry ice and immediately stored at -80°C. Meta-data variables essential to the design of each study were identified and used to determine sample analysis orders that were uncorrelated with those factors using in-house software, avoiding the potential for confounding critical clinical variables with analytical run order effects. For each study, this order was preloaded into an in-house laboratory information management system (LIMS). Samples were then sorted into sets of 80 using aluminum racks (9x9 position format) cooled by direct contact with dry ice to ensure that all samples remained frozen for the duration of the sorting exercise. Completed sets were stored at -80°C until required for subsequent steps.
Once sorted, individual urine sample sets were reformatted into 96-well plates. This step required the overnight thawing of a set of 80 samples at 4°C, mixing of each individual sample by vortexing, and transference of the liquid contents of each sample to a well within a 96-deep-well polypropylene plate (2 mL, Eppendorf). During this process, each sample was checked against a LIMS-generated map of sample identifiers and positions in the 96-well plate to validate the batch composition and sample order. Study samples were added only to the wells within the first ten columns of rows A through H; columns 11 and 12 of the plate were reserved for the later addition of pooled quality control reference samples. The plate was sealed with a silicone cap mat and centrifuged at 3486 × g for 10 minutes at 4°C using an Eppendorf 5810R
centrifuge equipped with an A-2-DWP-AT rotor for the removal of suspended particulate matter such as cryoprecipitate, cellular debris, or crystalline material. The supernatant was aspirated and dispensed in pre-programmed volumes among 96-well polypropylene plates using an eight-channel 15-1200 µl Eppendorf Xplorer Plus pipette including 150 µL to a 0.5 mL plate (RPC), 50 µL to a 0.5 mL plate (HILIC) and 50 µL to a 0.3 mL plate (study reference sample, described subsequently). All plates were sealed with a silicone cap mat and returned to -80°C.
Long term reference (LTR), study reference (SR), and SR dilution series stock urine samples. Quality control (QC)
samples were utilized to support the assessment of data quality within each experiment. A pooled LTR urine sample is maintained by the laboratory and is used as an independent sample reference throughout all molecular profiling studies. To create this material, seventy-eight individual urine voids were collected in a single day from volunteer subjects. No screening criteria were used to assess the health status of the donors. All samples were stored at 4°C from collection until the following day when all samples were combined and aliquoted by the following procedure. Individual samples were centrifuged at 4°C for 15 minutes at 3214 × g and their supernatants combined in a 20 L polypropylene vessel. The pooled sample was homogenized in the vessel by gentle stirring using a Teflon®-coated magnetic stir bar and magnetic stir plate.
Aliquots were created by multiple iterations of dispensing 1L of pooled urine supernatant to a 1 L glass bottle and aliquoting that material into 15 mL polypropylene conical centrifuge tubes (Corning) using an Eppendorf 5-25 mL
Varispenser plus. This process was repeated until all of the reference material was aliquoted. All aliquots were stored at -80°C until required for further preparation. For each study, a sufficient volume of LTR sample (approximately 2 mL per 80 study samples) was thawed for RPC and HILIC assays and supplemented with the relevant RPC and HILIC MR mixtures in a 2:1 LTR:MR ratio, homogenized, and aliquoted to 1.7 mL polypropylene microcentrifuge tubes. All LTR materials were frozen at -80°C until required for analytical plate preparation.
A pooled SR sample was prepared for both studies, one representing the mean of samples within the Alzheimer's study and the other of all samples within the AIRWAVE study. Each SR was created by thawing the contents of each study's SR sample plates at 4°C and combining their contents in an 800 mL glass beaker. Optionally, individual samples determined to be unsuitable for UPLC-MS analysis (e.g. by sample prescreening techniques) may be removed from the individual wells prior to pooling in order to avoid incorporation of severely contaminated or outlying samples which may compromise the SR. The pooled sample was homogenized by swirling and portioned in an approximate 3:1 ratio for use with RPC and HILIC assays respectively. The RPC and HILIC sub-fractions were supplemented with the relevant RPC and HILIC MR mixtures in a 2:1 SR:MR ratio, homogenized, and aliquoted to 1.7 mL polypropylene microcentrifuge tubes. All SR materials were frozen at -80°C until required for analytical plate preparation.
Sample preparation for UPLC-MS analysis.
Individual aliquot plates were removed from -80°C storage approximately three hours prior to their scheduled analysis and thawed at 4°C. All study samples were diluted with ultrapure water (75 µL for RPC preparation and 25 µL for HILIC preparation), commensurate with the volume of QC sample dilution caused by the addition of MR. LTR stock and SR stock aliquots were thawed and their contents distributed among the wells of columns 11 and 12, respectively (225 µL for RPC analysis and 75 µL for HILIC analysis). Finally, the IS solution was added to all samples (75 µL for RPC preparation and 25 µL for HILIC preparation). Sample plates for RPC analysis were sealed with a silicone cap mat, mixed for one minute at 4°C using a MixMate (Eppendorf) operating at 850 rpm, and centrifuged for 10 minutes at 3486 × g. The supernatant was split between two analytical microwell plates, one for positive and one for negative ion mode UPLC-MS analysis. Acetonitrile was added to samples for HILIC analysis in a 3:1 ACN:sample ratio to better match the initial solvent conditions of the chromatographic method. The sample plate was then sealed with Thermo-Seal heat sealing foil sheets using a ALPS 50 V-Manual Heat Sealer (Thermo SCIENTIFIC) prior to mixing for one minute at 4°C using a MixMate (Eppendorf) operating at 850 rpm. The plates were subsequently centrifuged for 10 minutes at 3486 × g to remove any residual protein precipitated by this addition of organic solvent, and a 150 µl volume of the supernatant was decanted to a microplate for analysis. Prepared plates were loaded into a 2777C sample manager (Waters Corp., Milford, MA, USA) where they were held at 4°C under a constant flow of nitrogen until analysis.
A dilution series of SR samples (1%, 10%, 20%, 40%, 60%, 80% and 100% original concentration) was prepared for each assay type from thawed SR in the same manner described above except that they were prepared in bulk volume in
Eppendorf microcentrifuge tubes and the products were stored in polypropylene sample vials for analysis supporting multiple injections from the same stock. Prior to and immediately following the analysis of each experiment's samples, dilution series samples were analysed by repeated measurement aimed at weighting the ends of the series (10,10,5,3,3,5,and 10 consecutive replicate injections of the 1%, 10%, 20%, 40%, 60%, 80%, and 100% SR samples respectively).
UPLC-MS analysis of human urine samples. For each study, RPC(+), RPC(-), and HILIC(+) assays were conducted on three independent but identical UPLC-MS systems, the components of which have been described in the main text. Full loop injections with a five-fold overfill were used, aspirating and injecting 10 µl of prepared sample to the 2 µl loop.
While this volume is smaller than the volume used in other studies, a larger injection volume of the same sample (with the given system tuning) would produce a higher proportion of signals exceeding the dynamic range achievable by the system.
The optimized analytical methods used for each assay have been described above, and data were collected in centroid mode (whereby spectral peaks are converted to single point measurements representing the peak area and mass during the data acquisition). Samples found to have large concentrations of protein by first analyzing data acquired by NMR spectroscopy were not injected into the UPLC-MS system. These samples were removed from the acquisition list of selected assays, and the injection system was set up to perform a repeat injection of the last acquired SR or LTR sample, allowing the analysis of an incomplete plate to adhere to the expected schedule while allowing continuous analysis.
Removal of these sample analyses therefore did not alter the experimental size or total number of injections. Finally, three instances of sample misinjection affecting one SR sample and two LTR samples in the HILIC+ analysis of AW data were observed during collection of the raw data, and were therefore excluded from the study.
Targeted feature detection parameters. The calculated mass value and expected retention time for each reference standard was provided along with consistent windows of error in absolute mass (0.05 Da) and retention time (0.1 minutes).
The nearest peak detected within each window was selected for integration. Apex Track peak detection was used, allowing the automatic calculation of peak width and baseline noise with start and end thresholds of 0.0% and 0.5% respectively. No chromatographic peak smoothing was applied. All data were manually inspected to ensure proper peak selection and consistent peak integration. This analysis provided both the retention time and peak area values for all MR and internal standards in SR and LTR samples within each assay.
Untargeted feature extraction parameters. The raw data files were converted from .RAW format to .mzNLD format for pre-processing with Progenesis QI 2.1 (Waters Corp., Manchester, UK). Retention time alignment was performed using the central long-term-reference sample as a reference for each study. Peak detection was configured with a minimum chromatographic peak width of 0.01 minutes, and automatic noise detection set to a threshold of 2 units. Peak integration was performed between 0.3 and 10.5 minutes for RPC assays and between 0.0 and 7.5 minutes for the HILIC+ assay.
Isotopic peaks were automatically resolved according to the observed m/z and chromatographic peak-shape and their measurements combined into a single reported value. The number of feature groups produced by this method for the RPC+, RPC-, and HILIC+ assays of each study were 27444, 34637, and 22813 (AW) and 23373, 27204, and 26058 (ALZ). Feature numbers surviving the data filtration method described in the text were 22374, 26983, and 15664 (AW) and 20407, 21667, and 18176 (ALZ). However, we caution the reader against over interpretation of feature number data, as no attempt beyond deisotoping was made to collapse LC-MS feature sets into spectra related to individual chemical species. 
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